HAVCR2 and acute myeloid leukemia: Given the lack of previous reports showing the prognostic significance of TIM-3+ T cells in the BM, our data are somewhat consistent with previous reports showing an association between TIM-3+ immune cells in the PB and a worse prognosis in AML patients [16,43,44].